Phreesia, Inc.

Phreesia, Inc.

PHR
Phreesia, Inc.US flagNew York Stock Exchange
10.68
USD
-0.03
- -
660.15MMarket Cap
Phreesia, Inc.
PHR
(New York Stock Exchange)

Recent

price

10.68

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
51.89
54.14
6.15
3.76
4.27
5.36
6.53
7.29
8.04
8.23
Revenue per Share
-11.82
-8.16
-1.74
-0.69
-2.37
-3.36
-2.51
-1.02
0.04
0.15
Basic EPS, GAAP
-15.02
-6.48
-0.57
-0.4
-2.12
-1.81
-0.7
0.41
1.13
1.26
Free Cash Flow per Basic Share
- -
- -
0.74
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-108.98
-114.35
-14
-7.88
-8.61
-11.55
-13.61
-13.91
-13.37
-13.21
Book Value per Share
-113.35
-119.5
4.52
6.12
7.08
3.96
1.79
1.88
0.55
0.96
Tangible Book Value per Share
2
2
20
40
50
52
55
58
60
60
Basic Weighted Avg Shares
80
100
125
149
213
281
356
420
481
496
Sales/Revenue/Turnover
-18.23
-9.5
-12.26
-17.27
-54.78
-62.85
-38.3
-13.84
-1.38
0.69
Operating Margin (%)
10
12
14
16
21
25
29
28
31
35
Depreciation Expense
-18
-15
-20
-27
-118
-176
-137
-59
2
9
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
53.93
Effective Tax Rate (%)
-22.79
-15.08
-16.26
-18.36
-55.41
-62.71
-38.42
-13.94
0.48
1.85
Profit Margin (%)
11
5
96
217
318
183
86
89
97
115
Working Capital
20
30
22
8
9
3
6
9
93
86
LT Debt
-168
-211
102
263
417
288
251
265
337
359
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2.29
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Oct'26
Jan'26
Apr'27
ST Debt
7
9
6
LT Borrowings
3
90
85
LT Finance Leases
- -
3
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
60
61
62
Market Capitalization
1,340
802
555

Working Capital

FRC

in mil. unless spec.
Oct'26
Jan'26
Apr'27
Total Current Assets
241
280
267
Cash, Cash Equivalents & STI
106
74
75
Accounts Receivable, Net
80
93
83
Inventories
- -
- -
- -
Total Current Liabilities
99
183
152
Payables & Accruals
33
83
71
ST Debt
7
9
6
Deferred Revenue
30
50
40

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
9.49%
27.34%
Free Cash Flow
- -
105.39%
186.05%
Net Income, GAAP
- -
39.71%
-103.94%
Sales/Revenue/Turnover
- -
26.86%
14.48%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
101
102
107
110
420
2026
116
117
120
127
481
2027
131
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.35
-0.31
-0.25
-0.11
-1.02
2026
-0.07
0.01
0.07
0.02
0.04
2027
0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Business
Phreesia, Inc. is a healthcare technology company headquartered in Wilmington, Delaware, focused on providing software-as-a-service (SaaS) solutions that automate and manage patient intake and engagement for healthcare organizations across the United States and Canada. Founded in 2005, Phreesia offers an integrated platform that includes patient registration, appointment scheduling, clinical documentation, payment processing, insurance eligibility verification, patient-reported outcomes collection, and automated patient communication tools such as appointment reminders and satisfaction surveys. The company’s solutions help healthcare providers streamline workflows, enhance patient experiences, improve operational efficiency, and optimize revenue cycle management. Phreesia serves a broad range of healthcare providers, including hospitals, health systems, and ambulatory care centers. Recent major developments include the acquisition of AccessOne Parent Holdings, Inc. in 2025, expanding Phreesia’s suite of payment solutions with enhanced financial experience tools for patients. The company also acquired Access eForms in 2023 to broaden its electronic forms management capabilities. Phreesia has strengthened strategic alliances, notably joining the MEDITECH Alliance Program as an Innovator Partner in 2024, integrating its patient intake and revenue cycle management solutions with MEDITECH's healthcare software platform. In 2025, Phreesia launched VoiceAI, a conversational AI solution aimed at transforming call management in healthcare settings, and announced a multi-year collaboration with Sesame Workshop focused on improving child health engagement. Additionally, Phreesia is expanding into social determinants of health screening through a partnership with the North Carolina Department of Health and Human Services. The company facilitates over 150 million patient visits annually and continues to enhance its platform with AI-driven features such as automated appointment rescheduling and after-hours care management, positioning itself for continued growth and innovation in the healthcare technology sector.

Company News

APIChatGPT
  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines - PHR

  • PHREESIA, INC. (PHR) INVESTIGATION ALERT: Bernstein Liebhard Announces Investigation of Phreesia, Inc.

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines – PHR

  • DEADLINE ALERT for PHR, SRAD, CVLT, VERI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

  • PHR FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR

  • PHR DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR

  • Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

  • CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

  • DEADLINE ALERT for PHR, SRAD, CVLT, and VERI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

  • PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm

  • Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR

  • PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm

  • Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • PHREESIA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR

  • PHR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

  • PHR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

  • PHR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

  • PHREESIA DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR

  • PHREESIA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 13 Deadline in Securities Class Action - PHR